Guangdong True Health Medical Technology Development Co., Ltd. logo

Guangdong True Health Medical Technology Development Co., Ltd.

2697.HK

HKSEHealthcareMedical - Devices

最新資料

HK$759

+HK$91.00 · +13.62%

8月24日 下午4:08 HKT

2697.HK公司概覽

盤中時間採用HKT。市場資料可能有所延遲。

公司概況

公司網站

Guangdong True Health Medical Technology Development Co., Ltd. engages in in the research and development, manufacture and sale of surgical robots and disposables in the People's Republic of China and Hong Kong. The company offers products, such as percutaneous puncture surgery robots, includes TH-S1, TH-S, TH-S Pro and TH-SA; microwave ablation surgical robot for the treatment of liver and lung tumors; percutaneous microwave ablation surgical robot TH-X HMW approved for the treatment of liver tumors; AI-based 3D reconstruction software for medical imaging; and five additional product, including the TH-P series of compact percutaneous puncture surgical robots which are approved for lung and abdominal puncture, the MW150 microwave ablation device, the TH-X Cryo cryoablation robot, the TH-LS KI300 and TH-LS LU100 ex vivo organ preservation and assessment systems. The company was formerly known as True Health (Guangdong Hengqin) Medical Technology Co., Ltd. and changed its name to Guangdong True Health Medical Technology Development Co., Ltd. in October 2025. The company was incorporated in 2018 and is based in Zhuhai, China.

產業
Medical - Devices
部門
Healthcare
總部
CN
執行長
Hou Iam Cheong
上市以來
2026年6月30日
僱員
156

市場位置

日內區間

目前HK$759,

52週區間

目前HK$759,

開盤價
HK$668
前收盤價
HK$668
成交量
4.82萬
0.7× 平均值
平均成交量
6.92萬
日均成交量
市值
270.56億 HKD
貝塔
-0.9
市場參考 1
50天平均值
HK$595.88
高於平均水平+27.37%
200天平均值
HK$595.88
高於平均水平+27.37%

2697.HK同業公司

繼續GoAI的研究

在 GoAI 中研究2697.HK

research.disclaimer